01/30/2026
GLP-1 therapies are often reduced to weight loss, but they also impact inflammation, metabolism, brain health, and reward pathways. Research is expanding into neuroinflammation, cognitive decline, and craving regulation, including alcohol. At lower doses, the goal is not aggressive appetite suppression but supporting overall health in a sustainable way. GLP-1s are here to stay and will be integral to longevity and wellness beyond weight loss.